Wells Fargo & Co (WFC), Dow Chemical Co (DOW) and Pfizer Inc. (PFE): Mizuho Securities USA Inc.’s Largest Buys

Share on FacebookTweet about this on TwitterShare on Google+Share on RedditShare on LinkedInPrint this pageEmail this to someone

Mizuho Securities USA Inc. was active in the second quarter 2015. The fund initiated 88 brand new positions and increased exposure to some other 33 stocks.

Mizuho Securities USA Inc. also lowered holdings in 66 stocks and sold out of a whopping 120 stocks. Apple Inc. (NASDAQ:AAPL), Goldman Sachs Group Inc (NYSE:GS) and 3M Co (NYSE:MMM) bore the brunt in the massive purge.

At the end of the day, the value of the fund’s equity portfolio appreciated to $838.9 million in the second quarter, from $774.6 million in the first quarter 2015.

Mizuho Securities USA Inc. is most active in the Finance sector, making up a vast majority of its portfolio at 63%. The fund also has substantial exposure to Technology and Healthcare industries.

Here is a brief look at Mizuho Securities USA Inc.’s largest buys during the second quarter: Wells Fargo & Co (NYSE:WFC), Dow Chemical Co (NYSE:DOW) and Pfizer Inc. (NYSE:PFE).

Largest buys

Brand new position in Wells Fargo (WFC)

Mizuho Securities USA Inc. launched a fresh position in Wells Fargo & Co (NYSE:WFC), taking up 949,400 shares in the company at the end of 2Q2015. The stake was valued at $53.4 million at the end of the latest quarter.

Fresh stake of 500,000 shares in Dow Chemical (DOW)

Mizuho Securities USA Inc. made a fresh move in Dow Chemical Co (NYSE:DOW) during the second quarter. The fund acquired 500,000 shares in the company, a stake that was valued at $25.6 million at the end of the quarter.

Dollar value of stake in Pfizer (PFE) jumped to $18 million

Mizuho Securities USA Inc. showed confidence in Pfizer Inc. (NYSE:PFE), taking up more shares in the drug company during the second quarter 2015. The fund reported owning 538,658 shares in Pfizer at the end of the second quarter, significantly up from 87,440 shares at the end of the first quarter 2015. The dollar value of the new stake in Pfizer stood above $18 million at the end of the latest quarter, compared to just about $3 million at the end of the previous quarter.

Neha Gupta

Neha Gupta has been in the financial space for over six years now. Gupta earned her MBA degree from Symbiosis Centre of Distance Learning in 2009 and her passion for finance led her to pursue Chartered Financial Analyst (CFA) course. She has successfully completed Level II of her CFA. She is a veteran in article writing, which is depicted in her numerous pieces published on SeekingAlpha, Nextiphonenews, InsiderMonkey, MarketWatch, and Techinsider. Her crisp and eloquent writing finds its best place in Researchcows, where emphasis is given on developing rich content for various websites, products, business plans, trainings, and book writing.

You may also like...

More in AAPL, DOW, GS, MMM, PFE
jlb associates
Apple Inc. (AAPL), Oracle Corporation (ORCL) and Microsoft Corporation (MSFT): JLB & Associates Inc’s Prominent Tech Picks

JLB & Associates Inc has reported in the latest 13F filing that the value of its equity portfolio appreciated to...

Close